» Articles » PMID: 21566082

The Induction of KLF5 Transcription Factor by Progesterone Contributes to Progesterone-induced Breast Cancer Cell Proliferation and Dedifferentiation

Overview
Journal Mol Endocrinol
Date 2011 May 14
PMID 21566082
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Progesterone (Pg) promotes normal breast development during pregnancy and lactation and increases the risk of developing basal-type invasive breast cancer. However, the mechanism of action of Pg has not been fully understood. In this study, we demonstrate that the mRNA and protein expression of Klf5, a pro-proliferation transcription factor in breast cancer, was dramatically up-regulated in mouse pregnant and lactating mammary glands. Pg, but not estrogen and prolactin, induced the expression of Krüpple-like factor 5 (KLF5) in multiple Pg receptor (PR)-positive breast cancer cell lines. Pg induced the KLF5 transcription through PR in the PR-positive T47D breast cancer cells. Pg-activated PR increased the KLF5 promoter activity likely through binding to a Pg response element at the KLF5 promoter. Importantly, Pg failed to promote T47D cell proliferation when the KLF5 induction was blocked by small interfering RNA. KLF5 is essential for Pg to up-regulate the expression of cell cycle genes, including CyclinA, Cdt1, and E2F3. In addition, KLF5 overexpression was sufficient to induce the cytokeratin 5 (CK5) expression, and the induction of CK5 by Pg was significantly reduced by KLF5 small interfering RNA. Consistently, the expression of KLF5 was positively correlated with that of CK5 in a panel of breast cancer cell lines. Taken together, we conclude that KLF5 is a Pg-induced gene that contributes to Pg-mediated breast epithelial cell proliferation and dedifferentiation.

Citing Articles

Epigenetic regulation of mRNA mediates the phenotypic plasticity of cancer cells during metastasis and therapeutic resistance (Review).

Zhang C, Liang S, Zhang H, Wang R, Qiao H Oncol Rep. 2023; 51(2).

PMID: 38131215 PMC: 10777459. DOI: 10.3892/or.2023.8687.


New insights into KLFs and SOXs in cancer pathogenesis, stemness, and therapy.

Zeng L, Zhu Y, Moreno C, Wan Y Semin Cancer Biol. 2023; 90:29-44.

PMID: 36806560 PMC: 10023514. DOI: 10.1016/j.semcancer.2023.02.003.


A multi-tissue transcriptomic landscape of female mice in estrus and diestrus provides clues for precision medicine.

Zhou Y, Yan H, Liu W, Hu C, Zhou Y, Sun R Front Cell Dev Biol. 2023; 10:983712.

PMID: 36589755 PMC: 9800588. DOI: 10.3389/fcell.2022.983712.


Inhibitory effect of the novel tyrosine kinase inhibitor DCC-2036 on triple-negative breast cancer stem cells through AXL-KLF5 positive feedback loop.

Shen Y, Zhu Q, Xiao M, Yin L, Feng W, Feng J Cell Death Dis. 2022; 13(8):749.

PMID: 36042208 PMC: 9428169. DOI: 10.1038/s41419-022-05185-x.


Novel insights linking BRCA1-IRIS role in mammary gland development to formation of aggressive PABCs: the case for longer breastfeeding.

Castillo P, Aisagbonhi O, Saenz C, ElShamy W Am J Cancer Res. 2022; 12(1):396-426.

PMID: 35141026 PMC: 8822284.


References
1.
Fujiu K, Manabe I, Ishihara A, Oishi Y, Iwata H, Nishimura G . Synthetic retinoid Am80 suppresses smooth muscle phenotypic modulation and in-stent neointima formation by inhibiting KLF5. Circ Res. 2005; 97(11):1132-41. DOI: 10.1161/01.RES.0000190613.22565.13. View

2.
Zhao D, Zheng H, Zhou Z, Chen C . The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation. Cancer Res. 2010; 70(11):4728-38. DOI: 10.1158/0008-5472.CAN-10-0040. View

3.
Liu R, Zheng H, Zhou Z, Dong J, Chen C . KLF5 promotes breast cell survival partially through fibroblast growth factor-binding protein 1-pERK-mediated dual specificity MKP-1 protein phosphorylation and stabilization. J Biol Chem. 2009; 284(25):16791-16798. PMC: 2719315. DOI: 10.1074/jbc.M808919200. View

4.
JABARA A . Effects of progesterone on 9,10-dimethyl-1,2-benzanthracene-induced mammary tumours in Sprague-Dawley rats. Br J Cancer. 1967; 21(2):418-29. PMC: 2008112. DOI: 10.1038/bjc.1967.48. View

5.
Frigo D, Sherk A, Wittmann B, Norris J, Wang Q, Joseph J . Induction of Kruppel-like factor 5 expression by androgens results in increased CXCR4-dependent migration of prostate cancer cells in vitro. Mol Endocrinol. 2009; 23(9):1385-96. PMC: 2737557. DOI: 10.1210/me.2009-0010. View